UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
SCHEDULE 13G
 
(Amendment No. 3)*
 
Under the Securities Exchange Act of 1934
 
 
 
NxStage Medical, Inc.

(Name of Issuer)
 
 
Common Stock, par value $0.001 per share

(Title of Class of Securities)
 
 
67072V103

(CUSIP Number)
 
 
December 31, 2014

(Date of Event Which Requires Filing of this Statement)
 
   
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:  
 
o Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


 
1
 
 
                
CUSIP No.  67072V 103
 SCHEDULE 13G
Page 2 of 8
         
1
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                   
Mubadala Development Company PJSC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
 
 
 
3
SEC USE ONLY
              
                 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
                      
The Emirate of Abu Dhabi, United Arab Emirates
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
                     
Not applicable
6
SHARED VOTING POWER
                      
2,727,757
7
SOLE DISPOSITIVE POWER
                       
Not applicable
8
SHARED DISPOSITIVE POWER
                   
2,727,757
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          
2,727,757
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
                            
                                    
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                            
4.40%
12
TYPE OF REPORTING PERSON (See Instructions)
                             
CO
 
 
 
2

 
                               
CUSIP No.  67072V 103
 SCHEDULE 13G
Page 3 of 8
         
1
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                     
MDC Capital (Cayman) Limited, as trustee for Fifty First  Investment Company LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
 
 
 
3
SEC USE ONLY
                     
                            
4
CITIZENSHIP OR PLACE OF ORGANIZATION
                                
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
                        
Not applicable
6
SHARED VOTING POWER
                            
2,727,757
7
SOLE DISPOSITIVE POWER
                             
Not applicable
8
SHARED DISPOSITIVE POWER
                         
2,727,757
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                  
2,727,757
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
                           
                             
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                          
4.40%
12
TYPE OF REPORTING PERSON (See Instructions)
                               
CO
 
 
 
3

 
                                              
CUSIP No.  67072V 103
    
Page 4 of 8
    
      
This Amendment No. 3 amends and restates in its entirety the statement on Amendment No. 2 of Schedule 13G filed by the Reporting Persons listed in Item 2 with the Securities and Exchange Commission (the “Commission”) on April 28, 2014 which relates to the Common Stock, par value $0.001 per share, of NxStage Medical, Inc. (the “Issuer”).  The information set forth herein regarding percentages of beneficial ownership is based upon information obtained from the Issuer regarding the number of shares of Common Stock, par value $0.001 per share, disclosed as outstanding as of October 29, 2014 by the Issuer in its quarterly report on Form 10-Q for the period ended September 30, 2014, and filed with the Commission on November 7, 2014.
 
Item 1.
 
(a)
Name of Issuer:
 
NxStage Medical, Inc.
 
(b)
Address of Issuer’s Principal Executive Offices:
 
350 Merrimack St., Lawrence, MA.
 
Item 2.
 
(a)
Name of Person Filing:
 
 
(i)
Mubadala Development Company PJSC.
 
 
(ii)
MDC Capital (Cayman) Limited, as trustee for Fifty First  Investment Company LLC.
 
(b)
Address of Principal Business Office or, if none, Residence:
 
 
(i)
P.O. Box 45005, Abu Dhabi, United Arab Emirates.
 
 
(ii)
Intertrust Corporate Services (Cayman) Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9005, Cayman Islands.
 
(c)
Citizenship:
 
 
(i)
The Emirate of Abu Dhabi, United Arab Emirates.
 
 
(ii)
Cayman Islands.
 
(d)
Title of Class of Securities:
 
Common Stock, par value $0.001 per share
 
(e)
CUSIP Number:
 
67072V 103
 
 
 
4

 
                               
CUSIP No.  67072V 103
    
Page 5 of 8
           
                
Item 3.
 
Not applicable.
 
Item 4.  Ownership.
 
(a)
Amount Beneficially Owned:
 
2,727,757 shares are held of record by MDC Capital (Cayman) Limited (“MDC Capital (Cayman)”), as trustee for Fifty First Investment Company LLC.  MDC Capital (Cayman) and Fifty First Investment Company LLC are wholly-owned subsidiaries of Mubadala Development Company PJSC.
 
(b)
Percent of Class:  See line 11 of the cover sheets.
 
(c)
Number of shares as to which the person has:
 
 
(i)
sole power to vote or to direct the vote:  See line 5 of the cover sheets.
 
 
(ii)
shared power to vote or to direct the vote:  See line 6 of the cover sheets.
 
 
(iii)
sole power to dispose or to direct the disposition of:  See line 7 of the cover sheets.
 
 
(iv)
shared power to dispose or to direct the disposition of:  See line 8 of the cover sheets.
 
Item 5.  Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  x

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable.
 
Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
Not applicable.
 
Item 8.  Identification and Classification of Member of the Group.
 
Not applicable.
 
 
 
 
 
 
 
5

 
                               
CUSIP No.  67072V 103
 
Page 6 of 8
                         
                                         
Item 9.  Notice of Dissolution of Group.
 
Not applicable.
 
Item 10.  Certification.
                 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
 
 
 
6

 
                               
CUSIP No.  67072V 103
    
Page 7 of 8
                 
                       
SIGNATURE
           
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
              
 
MUBADALA DEVELOPMENT COMPANY PJSC
 
     
 
February 4, 2015
 
 
Date
 
     
 
/s/ Samer Halawa
 
 
Signature
 
     
 
Samer Halawa / Attorney in Fact
 
 
Name/Title
 
     
     
     
 
MDC CAPITAL (CAYMAN) LIMITED, AS TRUSTEE FOR FIFTY FIRST INVESTMENT COMPANY LLC
 
     
 
February 4, 2015
 
 
Date
 
     
 
/s/ Rodney Cannon
/s/ Hani Barhoush
 
 
Signature
 
     
 
Rodney Cannon / Director
Hani Barhoush / Director
 
 
Name/Title
 

 
 
 
 
 
 
 
 
 
 
7

 
                               
CUSIP No.  67072V 103
    
Page 8 of 8
                 
                       
AGREEMENT OF JOINT FILING
             
Pursuant to Rule 13d-1(k)(1) of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the statement on Schedule 13G filed herewith shall be filed on behalf of each of the undersigned.
                 
                              
 
MUBADALA DEVELOPMENT COMPANY PJSC
 
     
 
February 4, 2015
 
 
Date
 
     
 
/s/ Samer Halawa
 
 
Signature
 
     
 
Samer Halawa / Attorney in Fact
 
 
Name/Title
 
     
     
     
 
MDC CAPITAL (CAYMAN) LIMITED, AS TRUSTEE FOR FIFTY FIRST INVESTMENT COMPANY LLC
 
     
 
February 4, 2015
 
 
Date
 
     
 
/s/ Rodney Cannon
/s/ Hani Barhoush
 
 
Signature
 
     
 
Rodney Cannon / Director
Hani Barhoush / Director
 
 
Name/Title
 


 
 
 
 
 
 
 
 
 
 
 
 8

Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nxstage Medical Charts.
Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nxstage Medical Charts.